A practice can add patients, add visits, and add revenue — and watch its margin fall. To an owner watching the top line climb, this feels like a contradiction: how can more business make the business worse off? It isn't a contradiction, and the usual explanation is payer mix — the blend of who pays for the care you deliver, and how differently each one pays for the very same service.
Same service, different price
In most of healthcare, you do not set the price of what you provide. The contract with each payer does. The same visit, session, or procedure can reimburse at meaningfully different rates depending on whether it is covered by a commercial plan, a government program, or paid out of pocket. That means two providers doing identical clinical work can produce very different contribution margins based on nothing but whose patients happen to fill their schedules. Revenue measures activity; it does not measure which of that activity actually pays.
How growth quietly erodes margin
The trouble starts when growth arrives disproportionately from lower-reimbursing payers. Every additional visit still adds revenue, but it adds less margin — and because much of the cost to deliver care (clinician time, room, support staff) is effectively fixed in the moment, lower-reimbursing volume can be only marginally profitable or even loss-making once fully costed.
Consider a deliberately hypothetical clinic that grows visit volume by a fifth in a year, but the new visits skew heavily toward a plan that reimburses well below its historical blended rate. Revenue rises, and the growth looks like a success. Yet the average margin per visit falls, and if those lower-paying visits are filling slots that higher-paying patients would otherwise have used, total profit can actually decline even as the top line grows. The numbers here are illustrative, but the mechanism is entirely real.
The report that reveals it
You cannot manage a payer mix you cannot see. The single most clarifying report a payer-driven practice can build is contribution margin per visit by payer: net collections for each payer, minus the direct cost to deliver that care. Once that view exists, the picture usually reorganizes itself — the payers that look like volume are not always the payers that produce profit. Building this reliably depends on reporting clean enough to attribute both collections and cost accurately, and on the analytical discipline to keep it current rather than reconstructing it once a year.
The capacity dimension
The issue sharpens as a practice approaches capacity. A fully booked schedule is a fixed pie: every low-margin visit that fills a slot is a high-margin visit that did not. At that point payer mix is no longer just a question of averages — it is a question of what each booking displaces. A practice with open capacity can afford to be relaxed about mix; a practice at the ceiling cannot. The same appointment, offered to two different patients, can carry very different value to the business, and once the schedule is full that difference stops being theoretical. This is the moment when a deliberate view of which patients to prioritize — clinically appropriate and financially aware at the same time — starts to matter to survival, not just to margin.
What to actually do about it
Seeing the problem is most of the battle. Acting on it comes down to a handful of levers:
- Measure mix and margin monthly. Payer mix drifts; an annual glance is far too slow to catch it while you still have options.
- Know — and work — your worst contracts. Understand which payer agreements sit below your cost to serve, and whether they can be renegotiated, re-tiered, or responsibly exited.
- Manage the front door. Scheduling and intake decisions shape mix over time; a deliberate policy beats passive drift.
- Align provider compensation with margin, not raw volume, so incentives don't quietly reward the least profitable work. This connects directly to how you design clinician compensation.
- Model expansion against mix. A new location or provider in a different payer environment changes the blend — sometimes for the better, sometimes not — and that should be modeled before capital is committed.
Growth is a strategy, not a goal
More revenue is only good news if it carries margin with it. The discipline is to grow the parts of the business that actually pay, and to know in advance what each new cohort of volume will do to the overall blend. That is a core part of the healthcare CFO work we do, and it is exactly the kind of judgment a dedicated CFO is positioned to bring — someone close enough to the numbers to notice the drift before it shows up in the bank balance.
So when revenue rises and margin falls, resist the reflex to chase still more volume. Look at the mix instead. The practices that stay financially healthy while they grow are the ones that can see, month by month, not just how much they are billing, but who is paying — and what is left after the true cost of care.